Matches in Wikidata for { <http://www.wikidata.org/entity/Q61583825> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q61583825 description "article scientifique publié en 2010" @default.
- Q61583825 description "im Januar 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61583825 description "wetenschappelijk artikel" @default.
- Q61583825 description "наукова стаття, опублікована в січні 2010" @default.
- Q61583825 name "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)" @default.
- Q61583825 name "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer" @default.
- Q61583825 type Item @default.
- Q61583825 label "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)" @default.
- Q61583825 label "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer" @default.
- Q61583825 prefLabel "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)" @default.
- Q61583825 prefLabel "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer" @default.
- Q61583825 P1433 Q61583825-5F40EA0E-169D-409C-BCF5-54338622AE1D @default.
- Q61583825 P1476 Q61583825-2BFAC312-D653-447E-A5A3-2AC6C6364505 @default.
- Q61583825 P2093 Q61583825-0470513E-2CCE-4168-A671-7B032198502F @default.
- Q61583825 P2093 Q61583825-04F58CFA-0770-47BB-AC7C-9AA6E75EB4BE @default.
- Q61583825 P2093 Q61583825-7AD0757B-EF18-4260-8F56-39F90647BD55 @default.
- Q61583825 P2093 Q61583825-B863EAAA-4831-4001-B403-DA3C2E078CBD @default.
- Q61583825 P2093 Q61583825-D375F29B-2EB3-4BCB-8F35-3D87E7E0C27A @default.
- Q61583825 P2093 Q61583825-E49C0B41-FBC8-4D94-81A5-21D5C8373417 @default.
- Q61583825 P2093 Q61583825-EE37E9AC-92A0-40CC-A51F-835BE8B5D164 @default.
- Q61583825 P304 Q61583825-94278CA3-24F3-47C0-8DE7-33FD62510521 @default.
- Q61583825 P31 Q61583825-908AFAD1-EBF8-425D-A513-F834D679E746 @default.
- Q61583825 P356 Q61583825-8F92F505-5040-407B-8716-0EEBA7CCDE75 @default.
- Q61583825 P478 Q61583825-2F582A0C-0530-4EBA-BB74-7302E92A3D8B @default.
- Q61583825 P50 Q61583825-5C8CBA20-5991-4525-A853-7707F2B8CE88 @default.
- Q61583825 P577 Q61583825-1754934E-EF4C-47A9-A0E3-036A037FEB7C @default.
- Q61583825 P921 Q61583825-22B63D71-3BA0-4D96-B153-A7551F1D5BAE @default.
- Q61583825 P921 Q61583825-C5C884EC-CAC7-4F7D-A58C-EF855828143D @default.
- Q61583825 P356 S0169-5002(10)70102-1 @default.
- Q61583825 P1433 Q641464 @default.
- Q61583825 P1476 "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)" @default.
- Q61583825 P2093 "A. Jackson" @default.
- Q61583825 P2093 "E. Dean" @default.
- Q61583825 P2093 "F.H. Blackhall" @default.
- Q61583825 P2093 "J. Kosmin" @default.
- Q61583825 P2093 "O. Ataman" @default.
- Q61583825 P2093 "P. Keng Koh" @default.
- Q61583825 P2093 "R. Califano" @default.
- Q61583825 P304 "S33-S34" @default.
- Q61583825 P31 Q13442814 @default.
- Q61583825 P356 "10.1016/S0169-5002(10)70102-1" @default.
- Q61583825 P478 "67" @default.
- Q61583825 P50 Q37830473 @default.
- Q61583825 P577 "2010-01-01T00:00:00Z" @default.
- Q61583825 P921 Q3658562 @default.
- Q61583825 P921 Q5452194 @default.